Michael Ryan - Kiromic Biopharma Chief Officer

Insider

Michael Ryan is Chief Officer of Kiromic Biopharma
Age 56
Phone832 968 4888
Webhttps://www.kiromic.com

Michael Ryan Latest Insider Activity

Tracking and analyzing the buying and selling activities of Michael Ryan against Kiromic Biopharma stock is an integral part of due diligence when investing in Kiromic Biopharma. Michael Ryan insider activity provides valuable insight into whether Kiromic Biopharma is net buyers or sellers over its current business cycle. Note, Kiromic Biopharma insiders must abide by specific rules, including filing SEC forms every time they buy or sell Kiromic Biopharma'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Kiromic Biopharma Management Efficiency

The company has return on total asset (ROA) of (0.9194) % which means that it has lost $0.9194 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (11.2981) %, meaning that it created substantial loss on money invested by shareholders. Kiromic Biopharma's management efficiency ratios could be used to measure how well Kiromic Biopharma manages its routine affairs as well as how well it operates its assets and liabilities.
100%
Kiromic Biopharma currently holds 9.41 M in liabilities with Debt to Equity (D/E) ratio of 0.21, which may suggest the company is not taking enough advantage from borrowing. Kiromic Biopharma has a current ratio of 1.32, which is within standard range for the sector. Note, when we think about Kiromic Biopharma's use of debt, we should always consider it together with its cash and equity.
Debt59.11%Cash40.89%100%

Similar Executives

Showing other executives

INSIDER Age

Nandan BSImmix Biopharma
63
Steen KnudsenAllarity Therapeutics
64
Manuel DafonsecaSonnet Biotherapeutics Holdings
N/A
James JDAllarity Therapeutics
55
Susan DexterSonnet Biotherapeutics Holdings
70
Claus PedersenAllarity Therapeutics
52
JD MBAImmix Biopharma
N/A
LaBella MSZyVersa Therapeutics
66
Waldemar PriebeCns Pharmaceuticals
N/A
CPA CTPCns Pharmaceuticals
44
Gabriel BAImmix Biopharma
38
Laxminarayan BhatReviva Pharmaceuticals Holdings
60
MBA IVEnveric Biosciences
68
MD FAAAAIPalisade Bio
N/A
John CPAUnicycive Therapeutics
63
Denise CarterQuoin Pharmaceuticals Ltd
56
Joan BrownAllarity Therapeutics
70
Narayan PrabhuReviva Pharmaceuticals Holdings
53
Gordon JDQuoin Pharmaceuticals Ltd
61
Jason DavisVirax Biolabs Group
53
Sharon McBrayerPalisade Bio
N/A
Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. Kiromic BioPharma, Inc. was founded in 2006 and is headquartered in Houston, Texas. Kiromic Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 59 people. Kiromic Biopharma (KRBP) is traded on NASDAQ Exchange in USA. It is located in 7707 Fannin, Houston, TX, United States, 77054 and employs 31 people. Kiromic Biopharma is listed under Pharmaceutical Products category by Fama And French industry classification.

Management Performance

Kiromic Biopharma Leadership Team

Elected by the shareholders, the Kiromic Biopharma's board of directors comprises two types of representatives: Kiromic Biopharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Kiromic. The board's role is to monitor Kiromic Biopharma's management team and ensure that shareholders' interests are well served. Kiromic Biopharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Kiromic Biopharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
Michael Ryan, Chief Officer
Leonardo Mirandola, Chief Officer
JD CPA, CEO Director
Daniel Clark, Chief Officer
MD PharmD, Chief Staff

Kiromic Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Kiromic Biopharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Kiromic Biopharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Kiromic Biopharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kiromic Biopharma will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to HP could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace HP when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back HP - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling HP Inc to buy it.
The correlation of HP is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as HP moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if HP Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for HP can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Consideration for investing in Kiromic Stock

If you are still planning to invest in Kiromic Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kiromic Biopharma's history and understand the potential risks before investing.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Equity Valuation
Check real value of public entities based on technical and fundamental data
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories